Vertex Pharmaceuticals Incorporated (VRTX) — Stock Analysis & Fair Value

Vertex Pharmaceuticals Incorporated (VRTX) trades on NASDAQ at $546.12 (US). Market cap $138.61B. P/E 31.5. P/B 6.8. ROE 23.3%. dividend yield 0.0%. 52-week range $374.17–$560.25.

Sector: Healthcare — Biotechnology.

On getValue you can run 9 valuation models on VRTX — DCF, Reverse DCF, Dividend Discount Model (DDM), Cash Flow + IRR, Normalized P/E, Industry Multiple, Piotroski F-Score and NAV — alongside a WACC calculator, up to 10 years of income statement, balance sheet and cash-flow data, peer comparison and insights.

Open the full VRTX analysis · Key metrics & insights

getValue is an analysis tool for education, not investment advice. Figures are shown as reported; model outputs depend on your assumptions.